vigil neuroscience - Search News

News

Sanofi buys Vigil Neuroscience for $470m

Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi

Key Takeaways Vigil Neuroscience shares more than tripled Thursday after the company reached a deal to be acquired by Sanofi.French pharmaceutical giant Sanofi agreed to pay $8.00 per share in cash at closing,

· 1d · on MSN

· 2d · on MSN

Sanofi to buy Vigil Neuroscience in $470M deal (update)

· 2d

Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi

PharmTech20h

Sanofi to Acquire Vigil Neuroscience to Expand Neurodegenerative Disease Pipeline

Sanofi is acquiring Vigil Neuroscience, a biotech firm focused on novel neurodegenerative disease therapies, to boost its ...

Fierce Biotech2d

Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race

Sanofi’s 11 months watching over Vigil Neuroscience have led to a $470 million buyout. | Sanofi’s 11 months watching over ...

22h

Sanofi to spend $470M for Watertown biotech’s Alzheimer’s drug

About a year after investing in Vigil Neuroscience Inc., Sanofi is now acquiring the Watertown biotech and its treatment in ...

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates The Merger Of Vigil Neuroscience, Inc. (NASDAQ: VIGL)

We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. Attorney Advertising. (C) 2025 Monteverde & Associates PC ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results